Patients selected to maximise response & minimise adverse events in RA & PsA trials.
What implications does this have when we interpret the data & try to apply in clinic?
#EULAR2021 https://t.co/CocKlvjme4
Links:
03-06-2021
Links:
By downloading this material, I acknowledge that it may be used only for personal use and personal education and that I will accredit RheumNow.com as the source and owner of this material. Commercial use or mass reproduction of this material without permission from RheumNow (info@rheumnow.com) is prohibited.
